Incidence of acute kidney injury in critically ill patients receiving vancomycin with concomitant piperacillin-tazobactam, cefepime, or meropenem

Adam M. Blevins, Jennifer N. Lashinsky, Craig McCammon, Marin Kollef, Scott Micek, Paul Juang

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article numbere02658-18
JournalAntimicrobial Agents and Chemotherapy
Volume63
Issue number5
DOIs
StatePublished - May 2019

ASJC Scopus Subject Areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Keywords

  • Acute kidney injury
  • Cefepime
  • Meropenem
  • Piperacillin-tazobactam
  • Vancomycin

Cite this